BLyS - An essential survival factor for B cells: Basic biology, links to pathology and therapeutic target

Autoimmunity Reviews

Volumn 3, Issue 5, 2004, Pages 368-375

  Baker, Kevin P ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Cytokine; Receptor; Signaling; TNF family

Indexed keywords

B LYMPHOCYTE RECEPTOR; CYTOKINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 4; TUMOR NECROSIS FACTOR;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CELL MATURATION; CELL SPECIFICITY; CELLULAR IMMUNITY; CROSS LINKING; DISEASE COURSE; DISEASE SEVERITY; GERMINAL CENTER; HUMAN; NONHUMAN; PHENOTYPE; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME; STEM CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TARGET CELL; UPREGULATION;

ANIMALS; AUTOIMMUNE DISEASES; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; HUMANS; MEMBRANE PROTEINS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3342877696     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2004.02.001     Document Type: Review

References (40)

1. Moore P.A., Belvedere O., Orr A., Pieri K., LaFleur D.W., Feng P., et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science. 285:1999;260-263
2. Nardelli B., Belvedere O., Roschke V., Moore P.A., Olsen H.O., Migone T.S., et al. Synthesis and release of B lymphocyte stimulator from myeloid cells. Blood. 97(1):2001;198-204
3. Gorelik L., Gilbride K., Dobles M., Kalled S.L., Zandman D., Scott M.L. Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells. J. Exp. Med. 198(6):2003;937-945
4. Liu Y., Hong X., Kappler J., Jiang L., Zhang R., Xu L., et al. Ligand-receptor binding revealed by the TNF family member TALL-1. Nature. 423(6935):2003;49-56
5. Craxton A., Magaletti D., Ryan E.J., Clark E.A. Macrophage- and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood. 101(11):2003;4464-4471
6. Gavin A.L., Ait-Azzouzene D., Ware C.F., Nemazee D. DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF. J. Biol. Chem. 278(40):2003;38220-38228
7. Do R.K., Hatada E., Lee H., Tourigny M.R., Hilbert D., Chen-Kiang S. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J. Exp. Med. 192(7):2000;953-964
8. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190(11):1999;1697-1710
9. Khare S.D., Sarosi I., Xia X.Z., McCabe S., Miner K., Solovyev I., et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 97(7):2000;3370-3375
10. Groom J., Kalled S.L., Cutler A.H., Olson C., Woodcock S.A., Schneider P., et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J. Clin. Invest. 109(1):2002;59-68
11. Gross J.A., Dillon S.R., Mudri S., Johnston J., Littau A., Roque R., et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. Impaired B cell maturation in mice lacking BLyS. Immunity. 15(2):2001;289-302
12. Avery D.T., Kalled S.L., Ellyard J.I., Ambrose C., Bixler S.A., Thien M., et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J. Clin. Invest. 112(2):2003;286-297
13. Vora K., Wang L., Rao S., Liu Z., Majeau G., Cutler A., et al. Cutting edge: germinal centers formed in the absence of B cell-activating factor belonging to the TNF family exhibit impaired maturation and function. J. Immunol. 171(2):2003;547-551
14. Rahman Z.S., Rao S.P., Kalled S.L., Manser T. Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice. J. Exp. Med. 198(8):2003;1157-1169
15. Gross J.A., Johnston J., Mudri S., Enselman R., Dillon S.R., Madden K., et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 404:2000;995-999
16. Yan M., Brady J.R., Chan B., Lee W.P., Hsu B., Harless S., et al. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr. Biol. 11(19):2001;1547-1552
17. Thompson J.S., Bixler S.A., Qian F., Vora K., Scott M.L., Cachero T.G., et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science. 293(5537):2001;2108-2111
18. Smith S.H., Cancro M.P. Cutting edge: B cell receptor signals regulate BLyS receptor levels in mature B cells and their immediate progenitors. J. Immunol. 170(12):2003;5820-5823
19. Tarte K., Zhan F., De Vos J., Klein B., Shaughnessy J.J. Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation. Blood. 102(2):2003;592-600
20. O'Connor B.P., Raman V.S., Erikson L.D., Cook W.J., Weaver L.K., Ahonen C., et al. BCMA is essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med. 199(1):2004;91-98
21. Hsu B.L., Harless S.M., Lindsley R.C., Hilbert D.M., Cancro M.P. Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators. J. Immunol. 168(12):2002;5993-5996
22. Seshasayee D., Valdez P., Yan M., Dixit V.M., Tumas D., Grewal I.S. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity. 18(2):2003;279-288
23. Varfolomeev E., Kischkel F., Martin F., Seshasayee D., Wang H., Lawrence D., et al. APRIL-deficient mice have normal immune system development. Mol. Cell. Biol. 24(3):2004;997-1006
24. Stein J.V., Lopez-Fraga M., Elustondo F.A., Carvalho-Pinto C.E., Rodriguez D., Gomez-Caro R., et al. APRIL modulates B and T cell immunity. J. Clin. Invest. 109(12):2002;1587-1598
25. Roschke V., Sosnovtseva S., Ward C.D., Hong J.S., Smith R., Albert V., et al. BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases. J. Immunol. 169(8):2002;4314-4321
26. Shu H.-B., Johnson H. B cell maturation protein is a receptor for the tumor necrosis factor family TALL-1. Proc. Natl. Acad. Sci. U. S. A. 97(16):2000;9156-9161
27. Xia X.-Z., Treanor J., Senaldi G., Khare S.D., Boone T., Kelley M., et al. TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation. J. Exp. Med. 192(1):2000;137-143
28. Xu L.-G., Shu H.-B. TNFR-associated factor-3 is associated with BAFF-R and negatively regulates BAFF-R-mediated NF-kappa B activation and IL-10 production. J. Immunol. 169(12):2002;6883-6889
29. Claudio E., Brown K., Park S., Wang H., Siebenlist U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat. Immunol. 3(10):2002;958-965
30. Hatada E.N., Do R.K., Orlofsky A., Liou H.C., Prystowsky M., MacLennan I.C., et al. NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-κB2 p100 to p52 in quiescent mature B cells. J. Immunol. 171(2):2003;761-768
31. Amanna I.J., Dingwall J.P., Hayes C.E. Enforced bcl-xL gene expression restored splenic B lymphocyte development in BAFF-R mutant mice. J. Immunol. 170(9):2003;4593-4600
32. Cheema G.S., Roschke V., Hilbert D.M., Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 44(6):2001;1313-1319
33. Stohl W., Metyas S., Tan S.M., Cheema G.S., Oamar B., Xu D., et al. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum. 48(12):2003;3475-3486
34. Tan S.M., Xu D., Roschke V., Perry J.W., Arkfeld D.G., Ehresmann G.R., et al. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum. 48(4):2003;982-992
35. Kayagaki N., Yan M., Seshasayee D., Wang H., Lee W., French D.M., et al. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity. 17(4):2002;515-524
36. Wang H., Marsters S.A., Baker T., Chan B., Lee W.P., Fu L., et al. TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. Nat. Immunol. 2(7):2001;632-637
37. Baker K.P., Edwards B.M., Main S.H., Choi G.H., Wager R.E., Halpern W.G., et al. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. Arthritis Rheum. 48(11):2003;3253-3265
38. Novak A.J., Bram R.J., Kay N.E., Jelinek D.F. Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival. Blood. 100(8):2002;2973-2979
39. Edwards J.C.W., Leandro M.J., Cambridge G. B-lymphocyte depletion therapy in rheumatoid arthritis and other autoimmune disorders. Biochem. Soc. Trans. 30(4):2002;824-828
40. Batten M., Groom J., Cachero T.G., Qian F., Schneider P., Tschopp J., et al. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192(10):2000;1453-1466